A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506145-38-00

Acronym

INCB 57643-103

Enrollment

Registered

2023-12-05

Start date

2021-05-11

Completion date

Unknown

Last updated

2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ET, MDS, or MDS/MPN, Treatment of participants with MF

None listed

Sex/Gender

All

Age

18 Years to No maximum

Finland, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026